JP2006501204A5 - - Google Patents

Download PDF

Info

Publication number
JP2006501204A5
JP2006501204A5 JP2004524697A JP2004524697A JP2006501204A5 JP 2006501204 A5 JP2006501204 A5 JP 2006501204A5 JP 2004524697 A JP2004524697 A JP 2004524697A JP 2004524697 A JP2004524697 A JP 2004524697A JP 2006501204 A5 JP2006501204 A5 JP 2006501204A5
Authority
JP
Japan
Prior art keywords
molecule
acid
bis
tetraazacyclododecane
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004524697A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006501204A (ja
Filing date
Publication date
Priority claimed from US10/209,993 external-priority patent/US20040022733A1/en
Application filed filed Critical
Publication of JP2006501204A publication Critical patent/JP2006501204A/ja
Publication of JP2006501204A5 publication Critical patent/JP2006501204A5/ja
Pending legal-status Critical Current

Links

JP2004524697A 2002-07-31 2003-07-23 薬物送達用及び撮像用複合リジン共重合体 Pending JP2006501204A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/209,993 US20040022733A1 (en) 2002-07-31 2002-07-31 Conjugated lysine copolymers
PCT/US2003/022913 WO2004011034A1 (en) 2002-07-31 2003-07-23 Conjugated lysine copolymers for drug delivery and imaging

Publications (2)

Publication Number Publication Date
JP2006501204A JP2006501204A (ja) 2006-01-12
JP2006501204A5 true JP2006501204A5 (OSRAM) 2006-09-14

Family

ID=31187190

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004524697A Pending JP2006501204A (ja) 2002-07-31 2003-07-23 薬物送達用及び撮像用複合リジン共重合体

Country Status (5)

Country Link
US (1) US20040022733A1 (OSRAM)
EP (1) EP1526873A1 (OSRAM)
JP (1) JP2006501204A (OSRAM)
AU (1) AU2003259208A1 (OSRAM)
WO (1) WO2004011034A1 (OSRAM)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005063304A2 (en) * 2003-12-24 2005-07-14 Board Of Regents, The University Of Texas_System Poly (l-glutamic acid) paramagnetic material complex and use as a biodegradable mri contrast agent
US20050271585A1 (en) * 2004-06-07 2005-12-08 General Electric Company Extended conjugated polymers
RU2007140391A (ru) * 2005-04-01 2009-05-10 Дзе Борд Оф Риджентс Оф Дзе Юниверсити Оф Техас Систем (Us) Поли(пептид) как хелатор: способы получения и применения
CN103394101B (zh) * 2013-06-27 2014-10-29 浙江大学 一种基于赖氨酸的高分子mri造影剂及其制备方法
US10610608B2 (en) 2013-08-01 2020-04-07 Rochester Institute Of Technology Modular imaging agents containing amino acids and peptides
US10927132B2 (en) 2015-02-27 2021-02-23 Rochester Institute Of Technology Transmetalation methods for the synthesis of PET and SPECT imaging agents

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4957939A (en) * 1981-07-24 1990-09-18 Schering Aktiengesellschaft Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging
US4431968A (en) * 1982-04-05 1984-02-14 General Electric Company Method of three-dimensional NMR imaging using selective excitation
US4665365A (en) * 1985-01-07 1987-05-12 General Electric Company Method for reversing residual transverse magnetization due to phase-encoding magnetic field gradients
US5554748A (en) * 1989-04-07 1996-09-10 Nycomed Salutar, Inc. Adducts of macrocyclic chelants
US5762909A (en) * 1995-08-31 1998-06-09 General Electric Company Tumor targeting with polymeric molecules having extended conformation
US6441025B2 (en) * 1996-03-12 2002-08-27 Pg-Txl Company, L.P. Water soluble paclitaxel derivatives
US6121775A (en) * 1998-06-16 2000-09-19 Beth Israel Deaconess Medical Center, Inc. MRI imaging method and apparatus
US6235264B1 (en) * 1999-12-01 2001-05-22 General Electric Company Medical imaging method for characterizing tumor angiogenesis using polymeric contrast agents
US6685915B2 (en) * 1999-12-01 2004-02-03 General Electric Company Extended-linear polymeric contrast agents, and synthesizing methods, for medical imaging

Similar Documents

Publication Publication Date Title
JP7449864B2 (ja) エバンスブルー誘導体の化学結合体ならびに前立腺癌を標的とするための放射線療法および造影剤としてのその使用
Yang et al. Gd (iii) chelates for MRI contrast agents: from high relaxivity to “smart”, from blood pool to blood–brain barrier permeable
CN111132700B (zh) 双模放射性示踪剂与治疗剂
CN111285918B (zh) 用于psma靶向的成像和放射疗法的金属/放射性金属标记的psma抑制物
Lu et al. Poly (l-glutamic acid) Gd (III)-DOTA conjugate with a degradable spacer for magnetic resonance imaging
Tan et al. Synthesis and evaluation of nanoglobular macrocyclic Mn (II) chelate conjugates as non-gadolinium (III) MRI contrast agents
CA2405469A1 (en) Integrin binding peptide derivatives
TWI238820B (en) Radiopharmaceuticals for diagnosing Alzheimer's disease
CN111182927A (zh) 用于成像和腔内放射治疗的psma配体
Anelli et al. Conjugates of gadolinium complexes to bile acids as hepatocyte-directed contrast agents for magnetic resonance imaging
CN108290924A (zh) 肽硫脲衍生物、含有其的放射性同位素标记化合物、和含有该化合物作为活性成分的用于治疗或诊断前列腺癌的药物组合物
JP2008201787A5 (OSRAM)
JP2024505374A (ja) デュアルモード放射性トレーサーおよびその療法
JP2010502585A5 (OSRAM)
WO2024044755A2 (en) Extracellular hsp90 (ehsp90)-targeted radiopharmaceuticals and use thereof
JP2009500410A (ja) イメージング剤としてのヒドラジドコンジュゲート
KR20230160806A (ko) 이중 모드 방사성 트레이서 및 치료법
JP2005525390A5 (OSRAM)
US20140363378A1 (en) Self-assembling molecules that accumulate in acidic tumor microenvironments
JP2006501204A (ja) 薬物送達用及び撮像用複合リジン共重合体
JP6292568B2 (ja) ウレア誘導体化合物、これを含有する放射性医薬
Gouin et al. Synthesis of a new chelating agent derived from phenylenediamine for application in radioimmunotherapy
JPWO2007061036A1 (ja) フラーレン誘導体を用いた造影剤
Shen et al. Synthesis and properties of neutral gadolinium and technetium-99m-labeled complexes
JP2025521837A (ja) 線維芽細胞活性化タンパク質を標的化する前駆体および放射性トレーサー